Futura Medical PLC MED2002 Additional Patent Filing (5755Y)
06 March 2017 - 6:00PM
UK Regulatory
TIDMFUM
RNS Number : 5755Y
Futura Medical PLC
06 March 2017
For immediate release 6 March 2017
Futura Medical plc
("Futura" or the "Company")
MED2002 Additional Patent Filing
Futura Medical plc (AIM: FUM), the innovative healthcare company
focused on advanced transdermal technology, is pleased to announce
that it has filed a new formulation patent with the UK Intellectual
Property Office in connection with MED2002, the Company's novel
topical gel for the treatment of erectile dysfunction.
This patent application has the potential to extend MED2002's
patent life worldwide through to 2038, thereby significantly
increasing the opportunity for licensing partners to generate
higher revenues and profits from the commercialisation of
MED2002.
The new patent includes intellectual property confirmed by the
Company's pivotal efficacy study of MED2002, the results of which
were announced in September 2016.
MED2002's current patent protection runs until August 2028 in
the USA and August 2025 in Europe.
James Barder, Futura's Chief Executive, commented: "This latest
patent filing has the potential to extend MED2002's patent
protection worldwide through to 2038, significantly extending the
product's commercial window and increasing its attractiveness to
licensing partners."
This announcement contains inside information.
For further information please contact:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0) 1483 685
670
Email to: james.barder@futuramedical.com www.futuramedical.com
N+1 Singer (Nominated
Adviser and Broker)
Aubrey Powell / Liz Yong Tel:+44 (0) 20 7496 3000
For media enquiries please
contact:
Buchanan
Mark Court / Sophie Cowles Tel: +44 (0) 20 7466
/ Stephanie Watson 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops
innovative products for consumer healthcare. The Company is
developing a portfolio of products and its strategy is to license
their manufacture and distribution to major pharmaceutical and
healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on
the AIM market of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCJFMFTMBJMMLR
(END) Dow Jones Newswires
March 06, 2017 02:00 ET (07:00 GMT)
Futura Medical (LSE:FUM)
Historical Stock Chart
From Apr 2024 to May 2024
Futura Medical (LSE:FUM)
Historical Stock Chart
From May 2023 to May 2024